Dr. Mark C Paznansky

Dr. Poznansky serves as both the scientific founder and scientific advisory board member to help advise on the immunology of preclinical and clinical studies of cancer immunotherapies developed by Voltron along with the design of early clinical research and testing in the hospital setting, along with gathering additional academic and clinical KOLs to serve on the SAB.